학술논문
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study
Document Type
Article
Author
Source
In: Therapeutic Advances in Gastroenterology . (Therapeutic Advances in Gastroenterology, 2021, 14)
Subject
Language
English
ISSN
17562848
1756283X
1756283X